Article
RNA splicing, cell signaling, and response to therapies.
Current opinion in oncology - 1 Jan 2016
Abou Faycal Cherine, Gazzeri Sylvie, Eymin Beatrice
Abstract excerpt
PURPOSE OF REVIEW: PremRNA alternative splicing is more a rule than an exception as it affects more than 90% of multiexons genes and plays a key role in proteome diversity. Here, we discuss some recent studies published in the extensively growing field linking RNA splicing and cancer. RECENT FINDINGS: These last years, the development of high-throughput studies together with appropriate bioinformatic tools have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
